Terms: = Lung cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
156 results:
1. Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer.
Wu Y; Zhang J; Zhao J; Wang B
BMC Pulm Med; 2024 Apr; 24(1):159. PubMed ID: 38561695
[TBL] [Abstract] [Full Text] [Related]
2. The role of hmga2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway.
Qian S; Wang F; Liao W; Liu J
Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
[TBL] [Abstract] [Full Text] [Related]
4. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes.
Zhu J; Wang R; Yang C; Shao X; Zhang Y; Hou J; Gao Y; Ou A; Chen M; Huang Y
J Control Release; 2024 Feb; 366():328-341. PubMed ID: 38168561
[TBL] [Abstract] [Full Text] [Related]
5. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
[TBL] [Abstract] [Full Text] [Related]
6. Development of a Highly
Gadre S; M M; Chakraborty G; Rayrikar A; Paul S; Patra C; Patra M
J Med Chem; 2023 Oct; 66(19):13481-13500. PubMed ID: 37784224
[TBL] [Abstract] [Full Text] [Related]
7. IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins.
Wang R; Ni C; Lou X; Zhang L; Wang L; Yao X; Duan X; Wan J; Li P; Qin Z
Int J Biol Sci; 2023; 19(5):1490-1508. PubMed ID: 37056922
[TBL] [Abstract] [Full Text] [Related]
8. Uterine MEIS1::NCOA2 Fusion Sarcoma With lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
9. Investigation of radiomics and deep convolutional neural networks approaches for glioma grading.
Aouadi S; Torfeh T; Arunachalam Y; Paloor S; Riyas M; Hammoud R; Al-Hammadi N
Biomed Phys Eng Express; 2023 Mar; 9(3):. PubMed ID: 36898146
[No Abstract] [Full Text] [Related]
10. A Novel Tri-Functional liposome Re-Educates "Cold Tumor" and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 Blockade.
Zhou F; Li X; Xue X; Li S; Fan G; Cai Y; Chang Z; Qu J; Liu R
Adv Healthc Mater; 2023 Apr; 12(11):e2202757. PubMed ID: 36652763
[TBL] [Abstract] [Full Text] [Related]
11. Silencing effects of mutant RAS signalling on transcriptomes.
Sers C; Schäfer R
Adv Biol Regul; 2023 Jan; 87():100936. PubMed ID: 36513579
[TBL] [Abstract] [Full Text] [Related]
12. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis.
Tian T; Lu Y; Lin J; Chen M; Qiu H; Zhu W; Sun H; Huang J; Yang H; Deng W
Redox Biol; 2022 Dec; 58():102544. PubMed ID: 36427397
[TBL] [Abstract] [Full Text] [Related]
13. Transdermal nanolipoplex simultaneously inhibits subcutaneous melanoma growth and suppresses systemically metastatic melanoma by activating host immunity.
Chen CH; Weng TH; Chuang CH; Huang KY; Huang SC; Chen PR; Huang HH; Huang LY; Shen PC; Chuang PY; Huang HY; Wu YS; Chang HC; Weng SL; Liao KW
Nanomedicine; 2023 Jan; 47():102628. PubMed ID: 36400317
[TBL] [Abstract] [Full Text] [Related]
14. CircRNA High Mobility Group At-hook 2 regulates cell proliferation, metastasis and glycolytic metabolism of nonsmall cell lung cancer by targeting miR-331-3p to upregulate High Mobility Group At-hook 2.
Li S; Zhao J; Wen S; Li M; Yu F; Wang W; Shao H; Jiang D
Anticancer Drugs; 2023 Jan; 34(1):81-91. PubMed ID: 36066399
[TBL] [Abstract] [Full Text] [Related]
15. A novel saponin liposomes based on the couplet medicines of
Guo C; Su Y; Wang H; Cao M; Diao N; Liu Z; Chen D; Kong M
Drug Deliv; 2022 Dec; 29(1):2743-2750. PubMed ID: 35999702
[TBL] [Abstract] [Full Text] [Related]
16. Identification of exosomal circRNA CD226 as a potent driver of nonsmall cell lung cancer through miR-1224-3p/high mobility group AT-hook 2 axis.
Peng L; Cao Y; Hu C
Anticancer Drugs; 2022 Nov; 33(10):1126-1138. PubMed ID: 35946568
[TBL] [Abstract] [Full Text] [Related]
17. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
Liu C; Zheng S; Wang Z; Wang S; Wang X; Yang L; Xu H; Cao Z; Feng X; Xue Q; Wang Y; Sun N; He J
Cancer Commun (Lond); 2022 Sep; 42(9):828-847. PubMed ID: 35811500
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
19. Boarding Oncolytic Viruses onto Tumor-Homing Bacterium-Vessels for Augmented cancer Immunotherapy.
Sun M; Yang S; Huang H; Gao P; Pan S; Cheng Z; He Z; Wang Z; Sun J; Liu F
Nano Lett; 2022 Jun; 22(12):5055-5064. PubMed ID: 35583490
[TBL] [Abstract] [Full Text] [Related]
20. Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and hmga2.
Jia L; Liu M; An L; Wang H; Wang X
Pathol Res Pract; 2022 Jul; 235():153913. PubMed ID: 35552087
[TBL] [Abstract] [Full Text] [Related]
[Next]
